IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C

doi:10.3748/wjg.v18.i35.4892

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 35

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3688)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

476

HTML

2736

Figures (1-2)

247

Tables (1-2)

229

Sum=3688

Sep 21, 2012 (publication date) through Jan 23, 2025

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Sep 21, 2012; 18(35): 4892-4897
Published online Sep 21, 2012. doi: 10.3748/wjg.v18.i35.4892

Table 1 Characteristics of patients

IL28B polymorphism	n (%)	SVR (%)	Gender (M/F)	Age (yr)	BMI(kg/m²)
CC	13 (20)	77
CT	34 (53)	38
TT	17 (27)	6
All	64	39	27/37	44 ± 12	27 ± 5

The values of BMI and age given as arithmetic mean and standard deviation. CC, CT and TT: Single nucleotide polymorphisms at location rs12979860 IL28B; SVR: Sustained virological response; BMI: Body mass index; M/F: Male/female.

Citation: Cieśla A, Bociąga-Jasik M, Sobczyk-Krupiarz I, Głowacki MK, Owczarek D, Cibor D, Sanak M, Mach T. IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C. World J Gastroenterol 2012; 18(35): 4892-4897
URL: https://www.wjgnet.com/1007-9327/full/v18/i35/4892.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i35.4892